# Other Cancer Types

Polydatin has been studied in several additional cancer types beyond the better-developed colorectal, breast, lung, liver, oral, and blood-cancer literature.

### Other areas with preliminary evidence

#### Nasopharyngeal cancer

* Cytotoxic effects reported in cell-line studies

#### Laryngeal and cervical cancer

* Cell-cycle arrest and apoptosis linked to PDGF/Akt suppression, cytochrome c release, and PARP-related signalling

#### Ovarian cancer

* Antigrowth activity reported in 3D aggregate models
* Oxidative-stress and redox biology remain relevant themes

#### Brain-tumour relevance through resveratrol conversion

Polydatin contributes to the systemic resveratrol pool after metabolism, which is relevant to ongoing interest in blood-brain barrier penetration and brain-tumour contexts. That does not make polydatin a proven brain-cancer treatment, but it keeps the topic clinically relevant for CNS-focused readers.

### Practical interpretation

These are promising but still secondary evidence areas. They help expand the biological scope of polydatin, but should not be weighted the same as its stronger models.

### References

Uncovering the Anticancer Potential of Polydatin: A Mechanistic Insight\
<https://pmc.ncbi.nlm.nih.gov/articles/PMC9656535/>

{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}

{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/natural-medicines/polydatin-in-oncology/polydatin-evidence-by-cancer-type/other-cancer-types.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.